5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Non-Fasting
Clinical trial NCT00834587 · COMPLETED
Trial details
- NCT number
- NCT00834587
- Sponsor
- Teva Pharmaceuticals USA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Primary completion
- 2004-06-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.